TIMP3 regulates osteosarcoma cell migration, invasion, and chemotherapeutic resistances
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
TIMP3 regulates osteosarcoma cell migration, invasion, and chemotherapeutic resistances
Authors
Keywords
TIMP3, Osteosarcoma, Migration, Invasion, Cisplatin sensitivity
Journal
TUMOR BIOLOGY
Volume 37, Issue 7, Pages 8857-8867
Publisher
Springer Nature
Online
2016-01-10
DOI
10.1007/s13277-015-4757-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Tissue inhibitor of metalloproteinase-3 (TIMP3) promotes endothelial apoptosis via a caspase-independent mechanism
- (2015) Jian Hua Qi et al. APOPTOSIS
- CXCR1 knockdown improves the sensitivity of osteosarcoma to cisplatin
- (2015) Xiu-guo Han et al. CANCER LETTERS
- An update on chemotherapy for osteosarcoma
- (2015) Stefano Ferrari et al. EXPERT OPINION ON PHARMACOTHERAPY
- Overexpression of X-Box Binding Protein 1 (XBP1) Correlates to Poor Prognosis and Up-Regulation of PI3K/mTOR in Human Osteosarcoma
- (2015) Jielai Yang et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Combination of Hedgehog inhibitors and standard anticancer agents synergistically prevent osteosarcoma growth
- (2015) YOSHINOBU SAITOH et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- The role of TIMPs in regulation of extracellular matrix proteolysis
- (2015) Valerie Arpino et al. MATRIX BIOLOGY
- Membrane-type matrix metalloproteinases: Their functions and regulations
- (2015) Yoshifumi Itoh MATRIX BIOLOGY
- RBEL1 is required for osteosarcoma cell proliferation via inhibiting retinoblastoma 1
- (2015) HONGHUI TANG et al. Molecular Medicine Reports
- Timp3 loss accelerates tumour invasion and increases prostate inflammation in a mouse model of prostate cancer
- (2015) Hibret A. Adissu et al. PROSTATE
- Cell Death Signaling
- (2015) Douglas R. Green et al. Cold Spring Harbor Perspectives in Biology
- A novel action mechanism for MPT0G013, a derivative of arylsulfonamide, inhibits tumor angiogenesis through up-regulation of TIMP3 expression
- (2015) Chih-Ya Wang et al. Oncotarget
- Increasing cisplatin sensitivity by schedule-dependent inhibition of AKT and Chk1
- (2014) Lei Duan et al. CANCER BIOLOGY & THERAPY
- Downregulation of miR-221/222 enhances sensitivity of breast cancer cells to tamoxifen through upregulation of TIMP3
- (2014) R Gan et al. CANCER GENE THERAPY
- Depletion of C3orf1/TIMMDC1 Inhibits Migration and Proliferation in 95D Lung Carcinoma Cells
- (2014) Huiling Wu et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Knockdown of CXCR7 inhibits proliferation and invasion of osteosarcoma cells through inhibition of the PI3K/Akt and β-arrestin pathways
- (2014) YONG ZHANG et al. ONCOLOGY REPORTS
- MicroRNA-32 inhibits osteosarcoma cell proliferation and invasion by targeting Sox9
- (2014) Jian-Qiang Xu et al. TUMOR BIOLOGY
- New molecular insights into osteosarcoma targeted therapy
- (2013) Jilong Yang et al. CURRENT OPINION IN ONCOLOGY
- Silencing of Barkor/ATG14 sensitizes osteosarcoma cells to cisplatin-induced apoptosis
- (2013) ZHIFANG ZHAO et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- Matrix metalloproteinase 2 expression and survival of patients with osteosarcoma: a meta-analysis
- (2013) Xiaoyang Wen et al. TUMOR BIOLOGY
- STAT3 activation by IL-6 from mesenchymal stem cells promotes the proliferation and metastasis of osteosarcoma
- (2012) Bing Tu et al. CANCER LETTERS
- Glycogen Synthase Kinase-3β, NF-κB Signaling, and Tumorigenesis of Human Osteosarcoma
- (2012) Qing-Lian Tang et al. JNCI-Journal of the National Cancer Institute
- Phosphorylated c-Jun and Fra-1 induce matrix metalloproteinase-1 and thereby regulate invasion activity of 143B osteosarcoma cells
- (2011) Ryuichiro Kimura et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Targeting the translational apparatus to improve leukemia therapy: roles of the PI3K/PTEN/Akt/mTOR pathway
- (2011) A M Martelli et al. LEUKEMIA
- miR-130a targets MET and induces TRAIL-sensitivity in NSCLC by downregulating miR-221 and 222
- (2011) M Acunzo et al. ONCOGENE
- Human mesenchymal stem cells promote growth of osteosarcoma: Involvement of interleukin-6 in the interaction between human mesenchymal stem cells and Saos-2
- (2010) Zhen-Yu Bian et al. CANCER SCIENCE
- A novel gene P28GANK confers multidrug resistance by modulating the expression of MDR-1, Bcl-2, and bax in osteosarcoma cells
- (2010) Guowen Wang et al. MOLECULAR BIOLOGY
- miR-221&222 Regulate TRAIL Resistance and Enhance Tumorigenicity through PTEN and TIMP3 Downregulation
- (2009) Michela Garofalo et al. CANCER CELL
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search